Search Result "pegylated interferon and ribavirin"
Sofosbuvir, Pegylated Interferon and Ribavirin in the Treatment of an Egyptian Cohort with Hepatitis C Virus Infection in Real-Life Clinical Practice
Journal: Infectious Disorders - Drug Targets
Volume: 19 Issue: 2 Year: 2019 Page: 179-184
Author(s): Sherief Abd-Elsalam,Rehab Badawi,Sally Elnawasany,Mohamed Yousef,Loai Mansour,Nehad Hawash,Reham A. Elkhouly,Shaimaa Soliman,Amal Selim,Abdelrahman Kobtan,Asem Elfert
Structure, Biology, and Therapeutic Implications of Pegylated Interferon Alpha-2b
Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2139-2157
Author(s): Stephen Youngster, Yu-Sen Wang, Michael Grace, James Bausch, Ronald Bordens, Daniel F. Wyss
Pegylated Interferons for the Treatment of Chronic Hepatitis B
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 1 Issue: 1 Year: 2006 Page: 85-94
Author(s): Chun-Jen Liu, Jia-Horng Kao
Recent Advances in Pegylated Interferon Antiviral Therapy of Chronic Hepatitis C
Journal: Anti-Infective Agents in Medicinal Chemistry
Volume: 5 Issue: 4 Year: 2006 Page: 379-387
Author(s): Carla S. Coffin, Samuel S. Lee
Retrospective Results on the Treatment of Chronic Hepatitis C with Different Interferon Regimes in a General Hospital
Journal: Current Drug Therapy
Volume: 5 Issue: 1 Year: 2010 Page: 58-61
Author(s): Eugen Musch, Mouhamad Malek, Angeliki Chrissafidou
Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection
Journal: Current HIV Research
Volume: 7 Issue: 4 Year: 2009 Page: 447-455
Author(s): E. Angeli, A. Mainini, A. Cargnel, C. Uberti-Foppa, A. Orani, R. Carbone, M. Andreoni, M. Schiavini, R. Giorgi, G. Rizzardini, G. Gubertini
Efficacy of Sofosbuvir Plus Ribavirin with or Without Peginterferon- Alfa in Treatment of a Cohort of Egyptian Patients with Hepatitis C Virus Infection
Journal: Infectious Disorders - Drug Targets
Volume: 17 Issue: 2 Year: 2017 Page: 95-100
Author(s): Ossama A. Ahmed,Hany H. Kaisar,Nehad Hawash,Hossam Samir,Sherif S. T. Shabana,Mohamed Hassan A. Fouad,Fatma Rizk,Sherief Abd-Elsalam
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 2081-2092
Author(s): A. Picardi, U. Vespasiani Gentilucci, E. M. Zardi, D. DAvola, A. Amoroso, A. Afeltra
Role of Interleukin 28B Polymorphisms in Response to Interferon Based Therapy for Hepatitis C Virus Clearance
Journal: Current Drug Metabolism
Volume: 19 Issue: 3 Year: 2018 Page: 215-223
Author(s): Manu Asthana,Sushil Kumar Sahu,Amit Kumar,Suchitra Mohanty,Sudipta Chakrabarti,Piyanki Das,Nabanita Roy Chattopadhya,Koustav Chatterjee,Shivaram Prasad Singh,Shanmugam Rajasubramaniam,Tathagata Choudhuri
Current and Future Therapy for Chronic Hepatitis C Virus Liver Disease
Journal: Current Drug Targets - Infectious Disorders
Volume: 3 Issue: 3 Year: 2003 Page: 247-253
Author(s): G. Lake-Bakaar